首页> 外国专利> PEPTIDES WHICH SUPPRESS EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

PEPTIDES WHICH SUPPRESS EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

机译:抑制实验性过敏性脑脊髓炎的肽

摘要

Abstract of the DisclosureSynthetic compounds of the formula:-are disclosed wherein X is an integer of at least 0 and A andB each represent a divalent moiety of the formula:-wherein R1 and R5 are each selected from the residue ofan amino acid or a polypeptide; R2 representsthe residue of tryptophan or tyrosine; R3 representsthe residue of an amino acid; R4 representsthe residue of Iysine; arginine or histidine; a is aninteger of 0 to 4, inclusive; b and c are each integers of atleast 0: m is an integer of from 0 to 1, inclusive; and nis an integer of at least 1; provided that when R1 or R5 isthe residue of a polypeptide, the corresponding b or c is 1.The disclosure is also of intermediate compounds forpreparing the compounds of the above formula and derivativecompounds having biological activity.Disclosed also are pharmaceutical compositions whereinthe essential active ingredient is a synthetic compound ofthe invention and methods of using them for the prevention,suppression, treatment and diagnosis of multiple sclerosis.
机译:披露摘要下式的合成化合物:公开了其中X是至少0的整数且A和B各自代表下式的二价部分:其中R1和R5各自选自氨基酸或多肽; R2代表色氨酸或酪氨酸残基; R3代表氨基酸残基; R4代表赖氨酸的残留;精氨酸或组氨酸; a是一个0到4之间的整数(含); b和c分别是的整数至少为0:m为0到1之间的整数(含);和n是至少1的整数;前提是当R1或R5为多肽的残基,相应的b或c为1。本公开内容还涉及用于制备上式的化合物及其衍生物具有生物活性的化合物。还公开了药物组合物,其中必不可少的活性成分是发明和使用它们进行预防的方法,多发性硬化的抑制,治疗和诊断。

著录项

  • 公开/公告号CA1092600A

    专利类型

  • 公开/公告日1980-12-30

    原文格式PDF

  • 申请/专利权人 ST. LUKES HOSPITAL;

    申请/专利号CA19760243826

  • 发明设计人 HASHIM GEORGE A.;

    申请日1976-01-20

  • 分类号C07C103/52;

  • 国家 CA

  • 入库时间 2022-08-22 15:47:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号